Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Androgen Receptor Antagonists [MoA]

Known as: Androgen Receptor Antagonists, Androgen Receptor Inhibitor 
 
National Institutes of Health

Related topics

Related topics

5 relations
Androgen Receptor AntagonistsFlutamidebicalutamideenzalutamide
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Androgen Receptor Antagonists and Anti-Prostate Cancer Activities of Some Newly Synthesized Substituted Fused Pyrazolo-, Triazolo- and Thiazolo-Pyrimidine Derivatives
A series of substituted pyrazole, triazole and thiazole derivatives (2–13) were synthesized from 1-(naphtho[1,2-d]thiazol-2-yl… Expand
  • table 1
  • table 2
  • table 3
  • table 3
  • table 4
2013
2013
Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer
The human androgen receptor plays a major role in the development and progression of prostate cancer and represents a well… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
2013
2013
Small Molecule Therapeutics Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer
The human androgen receptor plays a major role in the development and progression of prostate cancer and represents a well… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
2012
2012
The Three Dimensional Quantitative Structure Activity Relationships (3D-QSAR) and Docking Studies of Curcumin Derivatives as Androgen Receptor Antagonists
Androgen receptor antagonists have been proved to be effective anti-prostate cancer agents. 3D-QSAR and Molecular docking methods… Expand
  • table 1
  • table 1
  • figure 1
  • table 2
  • figure 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE